Free Trial

Hyperfine Q1 2023 Earnings Report

Hyperfine logo
$0.85 -0.09 (-9.59%)
(As of 05:44 PM ET)

Hyperfine EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.16
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Hyperfine Revenue Results

Actual Revenue
$2.64 million
Expected Revenue
$2.20 million
Beat/Miss
Beat by +$440.00 thousand
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Hyperfine Earnings Headlines

Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Hyperfine, Inc. Reports Record Revenue Growth in Q3 2024
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat

Upcoming Earnings